Effect of rifampin on the pharmacokinetics of rosiglitazone in Korean healthy subjects.

被引：0
|
作者：
Park, J
Kim, K
Jung, W
Kim, S
Shin, J
机构：
[1] Gachon Med Sch, Inchon, South Korea
[2] Seonam Univ, Coll Med, Namwon, South Korea
[3] Inje Univ, Pusan, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 75卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2003.11.129
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P34 / P34
页数：1
相关论文
共 50 条
  • [41] Effect of Itraconazole or Rifampin on Itacitinib Pharmacokinetics When Administered Orally in Healthy Subjects
    Barbour, April M.
    Punwani, Naresh
    Epstein, Noam
    Landman, Robert
    Cimino, Evan
    Yuska, Brad
    Wang, Phillip
    He, Kevin
    Chen, Xuejun
    Yeleswaram, Swamy
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (12): : 1641 - 1647
  • [42] Evaluation of the Effect of Multiple Doses of Rifampin on the Pharmacokinetics and Safety of Ponatinib in Healthy Subjects
    Narasimhan, Narayana I.
    Dorer, David J.
    Davis, Jeffrey
    Turner, Christopher D.
    Sonnichsen, Daryl
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (05): : 354 - 360
  • [43] EFFECTS OF LAROPIPRANT ON THE PHARMACOKINETICS (PK) OF ROSIGLITAZONE IN HEALTHY SUBJECTS
    Schwartz, J. I.
    Stroh, M.
    Gao, B.
    Liu, F.
    Rosko, K.
    Zajic, S.
    Sisk, C. McCrary
    Ruckle, J.
    Wagner, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S93 - S93
  • [44] Effects of sitagliptin on the pharmacokinetics (PK)of rosiglitazone in healthy subjects
    Mistry, Goutam
    Bergman, Arthur
    Luo, Wen-Lin
    Cilissen, Caroline
    Haazen, Wouter
    Wagner, John
    Herman, Gary
    DIABETES, 2006, 55 : A463 - A463
  • [45] POPULATION PHARMACOKINETIC ANALYSIS OF LENALIDOMIDE IN HEALTHY KOREAN SUBJECTS.
    Park, J. -S.
    Jeon, J. -Y.
    Jang, K.
    Moon, S.
    Kim, M. -G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S67 - S67
  • [46] Effect of food on the pharmacokinetics of delayed-release valproate in healthy human subjects.
    Nangia, A
    Cullen, E
    Niecestro, R
    Friedhoff, L
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (09): : 1032 - 1032
  • [47] Pharmacokinetics (PK) and pharmacodynamics (PD) of lanoteplase in healthy subjects.
    Vachharajani, N
    Shyu, W
    Stouffer, B
    Raymond, R
    Liao, W
    Tay, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 180 - 180
  • [48] Population pharmacokinetics of cefixime in Chinese male healthy subjects.
    Cui, Y
    Zhou, Y
    Sun, P
    Zhao, X
    Liu, Y
    Sun, Z
    Lu, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P24 - P24
  • [49] Entecavir pharmacokinetics after multiple doses in healthy subjects.
    Yan, JH
    Bifano, M
    Nichola, P
    O'Mara, E
    Loizillon, E
    Zhang, DX
    Olsen, S
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1070 - 1070
  • [50] THE EFFECT OF MUTIPLE DOSING OF GINKO BILOBA ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CILOSTAZOL IN HEALTHY SUBJECTS.
    Yeo, C.
    Cho, H.
    Park, S.
    Lee, B.
    Shon, J.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S43 - S43
12345